Discover
DCOY
Decoy Therapeutics Inc.
7.62
1 x 7.40
1 x 9.62
bid
ask
+
0.43
5.98%
1 @ 07:20 AM
7.10 -0.52 (6.85%)
| Ytd | -2.18% | |
| 1y | -95.17% |
6.05
day range
8.18
4.32
52 week range
415.80
| Open | 6.38 | Prev Close | 7.19 | Low | 6.05 | High | 8.18 | Mkt Cap | 4.05M |
| Vol | 159.69K | Avg Vol | 230.68K | EPS | 106.79 | P/E | 0.07 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 6.23 | 200-d Avg | 16.07 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 2.28M | ||
| Research and Development Expense | 749.81K | ||
| Selling, General and Administrative Expense | 1.53M | ||
| Operating Income | -2.28M | ||
| Net Income | -2.22M | ||
| Net Income Common Stock | -2.22M | ||
| Net Income Common Stock (USD) | -2.22M | ||
| Consolidated Income | -2.22M | ||
| Earnings per Basic Share | -4.18 | ||
| Earnings per Basic Share (USD) | -4.18 | ||
| Earnings per Diluted Share | -4.18 | ||
| Earning Before Interest & Taxes (EBIT) | -2.22M | ||
| Earning Before Interest & Taxes (USD) | -2.22M | ||
| Weighted Average Shares | 531.97K | ||
| Weighted Average Shares Diluted | 531.97K | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.82M | ||
| Cash and Equivalents (USD) | 7.82M | ||
| Current Assets | 8.36M | ||
| Property, Plant & Equipment Net | 35.74K | ||
| Total Assets | 8.42M | ||
| Current Liabilities | 4.55M | ||
| Total Liabilities | 4.55M | ||
| Accumulated Retained Earnings (Deficit) | -96.67M | ||
| Shareholders Equity | 3.88M | ||
| Shareholders Equity (USD) | 3.88M | ||
| Assets Non-Current | 65.62K | ||
| Deferred Revenue | 3.23M | ||
| Trade and Non-Trade Payables | 1.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.92K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.89M | ||
| Net Cash Flow from Operations | -2.89M | ||
| Share Based Compensation | 213.04K | ||